TrialNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2024

Efficacy and safety of aticaprant, a kappa receptor antagonist, adjunctive to oral SSRI/SNRI antidepressant in major depressive disorder: results of a phase 2 randomized, double-blind, placebo-controlled study.

Mark E Schmidt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.